{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:33:17Z","timestamp":1761921197873,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014354","name":"Milstein Medical Asian American Partnership Foundation","doi-asserted-by":"publisher","award":["the Paul and Irma Milstein Program at Johns Hopkin Center on Aging and Immune Remodelings"],"award-info":[{"award-number":["the Paul and Irma Milstein Program at Johns Hopkin Center on Aging and Immune Remodelings"]}],"id":[{"id":"10.13039\/100014354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-023-00392-2","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T06:01:32Z","timestamp":1701237692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fundamental and frontier research of immune responses to influenza vaccines in human aging: from cross-sectional and longitudinal studies to clinical trials and the geroscience perspective"],"prefix":"10.1186","volume":"20","author":[{"given":"Sean X.","family":"Leng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"392_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00362-8","author":"B Wunderlich","year":"2023","unstructured":"Wunderlich B, et al. Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against Influenza in community-dwelling older adults over 75 years of age. Immun Ageing. 2023. https:\/\/doi.org\/10.1186\/s12979-023-00362-8.","journal-title":"Immun Ageing"},{"key":"392_CR2","doi-asserted-by":"crossref","unstructured":"Shapiro JR et al. The intersection of biological sex and gender in adverse events following seasonal Influenza vaccination in older adults. Immun Ageing (2023) https:\/\/doi.org\/10.1186\/s12979-023-00367-3","DOI":"10.1186\/s12979-023-00367-3"},{"issue":"1","key":"392_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41541-021-00412-6","volume":"6","author":"JR Shapiro","year":"2021","unstructured":"Shapiro JR, et al. Sex-specific effects of aging on humoral immune responses to repeated Influenza vaccination in older adults. NPJ Vaccines. 2021;6(1):147.","journal-title":"NPJ Vaccines"},{"key":"392_CR4","doi-asserted-by":"publisher","unstructured":"Frasca D et al. Obesity accelerates age defects in B cells, and weight loss improves B cell function. Immun Ageing (2023) https:https:\/\/doi.org\/10.1186\/s12979-023-00361-9","DOI":"10.1186\/s12979-023-00361-9"},{"key":"392_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00364-6","author":"T Xiao","year":"2023","unstructured":"Xiao T, et al. Immunogenicity and safety of quadrivalent Influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor. Immun Ageing. 2023. https:\/\/doi.org\/10.1186\/s12979-023-00364-6.","journal-title":"Immun Ageing"},{"key":"392_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/agm2.12103","volume":"3","author":"X Li","year":"2020","unstructured":"Li X, Leng SX. Influenza immunization among Chinese seniors: urgent calling for improving vaccination coverage, education, and research. Aging Med. 2020;3:12\u20135.","journal-title":"Aging Med"},{"key":"392_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-022-00304-w","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. The impact of circadian rhythms on the immune response to Influenza vaccination in middle-aged and older adults (IMPROVE): a randomised controlled trial. Immun Ageing. 2023. https:\/\/doi.org\/10.1186\/s12979-022-00304-w.","journal-title":"Immun Ageing"},{"key":"392_CR8","doi-asserted-by":"crossref","unstructured":"Schmader KE et al. Immunogenicity of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. Immun Ageing (2023) http:\/\/doi.org\/10.1186\/s12979-023-00355-7","DOI":"10.1186\/s12979-023-00355-7"},{"key":"392_CR9","doi-asserted-by":"crossref","unstructured":"Martin DE et al. The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial. Immun Ageing (2023) http:\/\/doi.org\/10.1186\/s12979-023-00343-x","DOI":"10.1186\/s12979-023-00343-x"},{"key":"392_CR10","doi-asserted-by":"crossref","unstructured":"Cadar AN et al. Targeting the hallmarks of aging to improve Influenza vaccine responses in older adults. Immun Ageing (2023) http:\/\/doi.org\/10.1186\/s12979-023-00348-6","DOI":"10.1186\/s12979-023-00348-6"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-023-00392-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T06:03:48Z","timestamp":1701237828000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-023-00392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/s12979-023-00392-2","relation":{},"ISSN":["1742-4933"],"issn-type":[{"type":"electronic","value":"1742-4933"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Sean Leng participated in Sanofi\u2019s global meningococcal vaccination initiative and International Advisory Board on SARS-CoV-2 vaccine development and engaged in speaking for GSK on Shingrix vaccine. Albert Shaw has a research grant from Boerhinger-Ingelheim. Both Sean Leng and Albert Shaw serve on the Editorial Board of Immunity and Ageing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}